It has been demonstrated that has-miR-181a-5p expression is reduced in PAH, and that this reduction contributes to the attenuation of inflammatory responses and vascular remodeling by targeting genes such as TNF-α. This evidence concerns the gene TNF and pulmonary arterial hypertension.